Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Schizophrenia
NCT00554840Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Nov 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of varenicline in nicotine dependence, sponsored by University of Maryland, Baltimore. Started Nov 2007; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00554840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554840.